公司名稱:南京康佰生物科技有限公司
地址:南京市雨花區長虹路222號
郵編:
電話:025-86880024
手機: 18066071954
聯系人: 蔣
傳真:
E-mail: duhaitao@cobioer.com
地址:南京市雨花區長虹路222號
郵編:
電話:025-86880024
手機: 18066071954
聯系人: 蔣
傳真:
E-mail: duhaitao@cobioer.com
CBP74066PDL1/TCR Activator/CHO細胞的詳細資料:
CBP74066 | |
I. Background | |
The binding of Programmed Cell Death Protein 1 (PD-1), a receptor expressed on activated T-cells, to its ligands, PD-L1 and PD-L2, negatively regulates immune responses. PD-1 ligands are found on most cancers, and the PD-1:PD-L1/2 interaction inhibits T-cell activity and allows cancer cells to escape immune surveillance. The PD-1:PD-L1/2 pathway is also involved in regulating autoimmune responses, making these proteins promising therapeutic targets for a number of cancers, as well as multiple sclerosis, arthritis, lupus, and type I diabetes. | |
II. Description | |
Recombinant CHO-K1 cells constitutively expressing human PD-L1 (Programmed Cell Death 1 Ligand 1, CD274, B7 homolog 1 (B7- H1), GenBank accession # NM_014143) an engineered T cell receptor (TCR) activator. | |
III. Introduction | |
Host Cell: | CHO-K1 |
Expressed gene: | PD-L1 |
Stability: | 32 passages |
Synonym(s): | Programmed Cell Death 1 Ligand 1, PDL1, PD-L1, B7 homolog 1, B7H1, B7-H1, CD274, PDCD1L1 |
Freeze Medium: | 90% FBS+10% DMSO |
Culture Medium: | F12K+10%FBS+2ug/ml puromycin+500ug/ml hygromycin |
Mycoplasma Testing: | Negative |
Storage: | Liquid nitrogen |
Application(s): | Screen for activators or inhibitors of PD-1 signaling in a cellular context , screen PD-L1 antibodies for binding affinity • Characterize the biological activity of PD-1 interactions with PD-L1 |
IV. Description of Host Cell Line | |
Organism: | Cricetulus griseus, hamster, Chinese |
Tissue: | Ovary |
Disease: | Hamster Chinese ovary |
Morphology: | Epitheloid cell |
Growth Properties: | Adherent |
Ⅴ. Representative Data | |
Figure 1.Recombinant CHO cells constitutively expressing human PD-L1 and an engineered T-cell receptor (TCR) activator. | |
Figure 2. Dose response curve of anti-PD-1 antibody on PD-1/PD-L1 Blockade Bioassay Model. | |